Abstract
In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Current Bioinformatics
Title:Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data
Volume: 9 Issue: 5
Author(s): Lian En Chai, Mohd Saberi Mohamad, Safaai Deris, Chuii Khim Chong, Yee Wen Choon and Sigeru Omatu
Affiliation:
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Abstract: In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Export Options
About this article
Cite this article as:
Chai En Lian, Mohamad Saberi Mohd, Deris Safaai, Chong Khim Chuii, Choon Wen Yee and Omatu Sigeru, Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data, Current Bioinformatics 2014; 9(5) . https://dx.doi.org/10.2174/1574893609666140421210333
DOI https://dx.doi.org/10.2174/1574893609666140421210333 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Relative In Vitro Potentials of Parthenolide to Induce Apoptosis and Cell Cycle Arrest in Skin Cancer Cells
Current Drug Discovery Technologies Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Current Molecular Medicine The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors
Current Molecular Medicine Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors
Current Gene Therapy Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery
Current Pharmaceutical Design Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Artemisinin, Promising Lead Natural Product for Various Drug Developments
Mini-Reviews in Medicinal Chemistry Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Current Pharmaceutical Design Hapten Recognition by T Cells: A Functional and Molecular View
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gold Nanostructures as Photothermal Therapy Agent for Cancer
Anti-Cancer Agents in Medicinal Chemistry The Early Bird Catches the Worm – Can Evolution Teach us Lessons in Fighting HIV?
Current HIV Research Vitamin D and Breast Cancer Incidence and Outcome
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Breast Cancer in the Personal Genomics Era
Current Genomics Functional Nanogels for Biomedical Applications
Current Medicinal Chemistry Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors in Cancer
Current Drug Targets